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Background 
Biomaterials play central roles in 
modern strategies in regenerative medicine 
and tissue engineering as designable 
biophysical and biochemical environments 
that direct cellular behavior and function. 
New generations of synthetic biomaterials 
are being developed at a rapid pace for use 
as three-dimensional extracellular  
microenvironments to mimic the 
regulatory characteristics of natural 
extracellular matrices (ECMs) and ECM-
bound growth  factors, both for therapeutic 
applications and basic biological studies. 
The ultimate decision of a cell to 
differentiate, proliferate, migrate, apoptosis 
or perform other specific functions is a 
coordinated response to the molecular 
interactions with these ECM effectors. The 
flow of information between cells and their 
ECM is highly bidirectional, as, for 
example, observed in processes involving 
ECM degradation and remodeling.  
Matrix metalloproteinases (MMP) are 
Zn and Ca dependent enzymes and 
represent a class of structural and functional 
kindred enzymes that are involved in 
altering the natural compounds of the 
extracellular matrix [1,2]. MMP are 
synthesized as zymogens that can be 
inhibited by 4 classes of natural inhibitors 
called TIMPs (tissue inhibitor for matrix 
metalloproteinases) [3]. MMP plays 
important roles in physiological processes, 
but their overexpression plays also crucial 
roles in pathological processes as multiple 
sclerosis, arthritis, Alzheimer disease and 
especially in cancer and metastasis [4-8]. 
Among these biological molecules we have 
investigated expression of  
metalloproteinase 8 (MMP-8) and 
metalloproteinase 9 (MMP-9) in the 
periimplantar tissues remodelling.  
Methodology 
We have performed an indirect 
immunohistochemical technique using 
hematoxilin/eosin (HE) staining by 
peroxidase induced conversion of DAB 
(3,3-diaminobenzidine), an enzyme 
conjugate, which reveals the localisation of 
antibody-bound antigenic sites by means of 
a coloured reaction. DAB, a chromogenic 
substrate for peroxidase, stains the antigen-
antibody sites in brown, indicating the 
presence of the metalloproteinases-8 
(MMP-8) in the cells surrounding the 
implant. MMP-8 are usually present in the 
neutrophils infiltrating the connective 
tissue or bone in an accute phase of 
inflamatory process. Data analysis was done 
using an Olympus BX40 optical microscope 
with a color CCD camera mounted on. We 
have also performed molecular docking and 
molecular dynamics investigations 
regarding simulations of the catalytic 
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domain of a known matrix 
metalloproteinase (MMP), in the absence 
of the substrate or a known inhibitor, 
starting from ProteinDataBank published 
data (ID-1QIB). This study emphasizes the 
role of the atomic position in this site 
regarding to further simulations for 
conceiving a rather modulating inhibitor 
for these enzymes. 
Results and conclusions 
Immunolabelling with MMP-8 is 
reduced and limited to the perivascular 
area. MMP-9 has a more diffuse presence, 
without precise localization and therefore 
shows no remodeling processes (1st and 
2ndtype). After 2 months MMP-8 
immunolabelling was more pronounced 
outside blood vessel walls as a proof of 
chronic inflammation. MMP-9 was found 
perivascular (in the wall of small capillaries) 
more diffuse but also more intense. This 
suggests a lot of active remodeling here (3rd 
and 4th type). For 2nd type MMP-9 is 
present in a diffuse but more intense way 
suggesting accelerated tissue remodeling. 
These preliminary phenomenon modulated 
by the presented molecules are crucial for 
newly grown bone tissue formation and 
healing, even allowing implant primary 
fixation. Molecular modelind and dynamic 
studies on MMP2 catalytic site showed that 
Root Mean Square Fluctuation (RMSF) 
was performed, compared with the NMR 
starting structure and the hydrophobic 
solvent accessible surface area (HSAS) of 
the MMP2 catalytic site. We have observed 
small fluctuations for the catalytic Zn area 
(high stability); however we have noticed 
some fluctuations, especially in some loop 
regions near the catalytic site of the MMP, 
in 192-250 region of the MMP2 PDB file. 
This study emphasizes the role of the 
atomic position in the catalytic site for 
MMPs, regarding to further simulations for 
conceiving a rather modulating inhibitor 
for these enzymes. 
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